NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025)
NovaBridge Biosciences (NBP) reported Free Cash Flow of -$14.6 million for Q4 2025, down 33.77% year-over-year from -$22.0 million in Q4 2024, and down 893.69% quarter-over-quarter from $1.8 million in Q3 2025.
NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 4 years of Free Cash Flow data on file, last reported at -$14.6 million in Q4 2025.
- Free Cash Flow for Q4 2025 came in at -$14.6 million, down 33.77% year-over-year; the trailing twelve-month figure through Dec 2025 was -$12.8 million (down 412.74% YoY), and the FY2025 annual result was -$20.6 million, up 60.87% from the prior year.
- Free Cash Flow retreated to -$14.6 million in Q4 2025 per NBP's latest filing, from $1.8 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $8.4 million in Q3 2024 and troughed at -$14.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 63,220.27 |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | -14.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.60 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Dec 31, 2024 | -10.91 Mn |
| Dec 31, 2024 | -10.91 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Dec 31, 2020 | -1.93 Mn |
| Dec 31, 2020 | -1.93 Mn |
| Sep 30, 2020 | 668,359.95 |
| Sep 30, 2020 | 668,359.95 |
| Dec 31, 2019 | -2.39 Mn |
| Dec 31, 2019 | -2.39 Mn |